These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29855198)

  • 1. Better to be in The Placebo Arm for Trials of Neurological Therapies?
    Kimmelman J
    Cell Transplant; 2018 Apr; 27(4):677-681. PubMed ID: 29855198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deception and the ethics of placebo.
    Stoessl AJ
    Int Rev Neurobiol; 2020; 153():147-163. PubMed ID: 32563286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ethical controversies on the use of placebo as control treatment in clinical trials in neurology].
    Lahuerta J; Gutiérrez Rivas E; Frías J; Gracia D; Dal-Ré R
    Neurologia; 2007 Mar; 22(2):106-13. PubMed ID: 17323236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended-release naltrexone versus standard oral naltrexone versus placebo for opioid use disorder: the NEAT three-arm RCT.
    Strang J; Kelleher M; Mayet S; Day E; Hellier J; Byford S; Murphy C; McLennan B; Shearer J; Ryan E; Marsden J
    Health Technol Assess; 2019 Jan; 23(3):1-72. PubMed ID: 30702059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Executive summary: The Emergency Neurologic Clinical Trials Network meeting--a National Institute of Neurological Disorders and Stroke symposium.
    Pancioli AM; Barsan WG; Conwit RA
    Acad Emerg Med; 2004 Oct; 11(10):1092-6. PubMed ID: 15466154
    [No Abstract]   [Full Text] [Related]  

  • 9. Patient Engagement in Neurological Clinical Trials Design: A Conference Summary.
    Cobb EM; Meurer W; Harney D; Silbergleit R; Lake BP; Clark C; Gipson D; Barsan W
    Clin Transl Sci; 2015 Dec; 8(6):776-8. PubMed ID: 26083566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of placebo assignment in clinical trials of Parkinson's disease.
    Goetz CG; Janko K; Blasucci L; Jaglin JA
    Mov Disord; 2003 Oct; 18(10):1146-9. PubMed ID: 14534918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'High hopes for treatment': Australian stakeholder perspectives of the clinical translation of advanced neurotherapeutics for rare neurological diseases.
    Nguyen CQ; Kariyawasam DST; Ngai TSJ; Nguyen J; Alba-Concepcion K; Grattan SE; Palmer EE; Hetherington K; Wakefield CE; Dale RC; Woolfenden S; Mohammad S; Farrar MA
    Health Expect; 2024 Jun; 27(3):e14063. PubMed ID: 38711219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).
    Brettschneider C; Lühmann D; Raspe H
    GMS Health Technol Assess; 2011 Feb; 7():Doc01. PubMed ID: 21468289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials.
    Daugherty CK; Ratain MJ; Emanuel EJ; Farrell AT; Schilsky RL
    J Clin Oncol; 2008 Mar; 26(8):1371-8. PubMed ID: 18227527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical methods in handling placebo effect.
    Raman R
    Int Rev Neurobiol; 2020; 153():103-120. PubMed ID: 32563284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical "placebo" controls.
    Tenery R; Rakatansky H; Riddick FA; Goldrich MS; Morse LJ; O'Bannon JM; Ray P; Smalley S; Weiss M; Kao A; Morin K; Maixner A; Seiden S
    Ann Surg; 2002 Feb; 235(2):303-7. PubMed ID: 11807373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in research and treatment of neurological disorders.
    Ferrer E
    Drug News Perspect; 2008 Jun; 21(5):282-9. PubMed ID: 18596993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can placebo controls reduce the number of nonresponders in clinical trials? A power-analytic perspective.
    Leon AC
    Clin Ther; 2001 Apr; 23(4):596-603. PubMed ID: 11354393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
    Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
    Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.